Back to Cardiology
Cardiologyv1998Evidence-Based

Framingham Risk Score for Hard Coronary Heart Disease

Estimates 10-year risk of myocardial infarction in patients aged 30-79 with no history of coronary heart disease or diabetes

Clinical Input Parameters

years
Range: 30 — 79 years
mg/dL
Range: 100 — 400 mg/dL
mg/dL
Range: 20 — 100 mg/dL
mmHg
Range: 90 — 200 mmHg
Clinical Assessment
Awaiting Parameters
risk percentage
—%
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Framingham Risk Score for Hard Coronary Heart Disease is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within cardiology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Gender-specific logarithmic regression equation using age, cholesterol levels, blood pressure, smoking status, and treatment history

Clinical Pearls & Practice Notes

  • Not recommended for patients with diabetes or known coronary heart disease
  • Uses gender-specific coefficients for calculation
  • Based on Framingham Heart Study population data from 1998
  • Estimates risk of hard CHD events (MI, coronary death)
  • Age range limited to 30-79 years for validation
  • Consider newer risk calculators (ASCVD) for more recent population data

Evidence & Literature Citations

  1. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97(18):1837-47. doi: 10.1161/01.cir.97.18.1837.
  2. D'Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008;117(6):743-53. doi: 10.1161/CIRCULATIONAHA.107.699579.
  3. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486-97. doi: 10.1001/jama.285.19.2486.

Score Interpretation Ranges

Low Risk0 – 5 pts

Low 10-year CHD risk

Borderline Risk5 – 10 pts

Borderline 10-year CHD risk

Intermediate Risk10 – 20 pts

Intermediate 10-year CHD risk

High Risk20 – 100 pts

High 10-year CHD risk

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.